1. Agouron Pharmaceuticals, Inc. (19 from 174 patents)

2. Syntex (u.s.a.) Inc. (3 from 932 patents)

3. Other (2 from 832,680 patents)

4. Pfizer Corporation (2 from 4,455 patents)

5. Novartis Ag (2 from 3,923 patents)

6. Bristol-myers Squibb Compnay (2 from 3,681 patents)

1. 12180291 - Anti-CCR7 antibody drug conjugates

2. 11634497 - Anti-CCR7 antibody drug conjugates

3. 8399647 - Alpha5-beta1 antibodies and their uses

4. 8039596 - Alpha 5-beta 1 antibodies and their uses

5. 7141587 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

6. 7141581 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

7. 6891044 - Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use

8. 6884890 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

9. 6849732 - Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation

10. 6774243 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates

11. 6635641 - Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

12. 6620828 - Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use

13. 6534524 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

14. 6531491 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

15. 6500948 - Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof